IABP, Ventricular Devices & ECMO

Match the Device to the Failing Function

The official blueprint explicitly names intra-aortic balloon pumping, temporary ventricular devices, VV- and VA-ECMO, and neurologic complications of LVADs and ECMO. Their common purpose is to maintain organ support while a reversible disorder recovers or while a definitive treatment is arranged. Their mechanisms differ. Knowing whether the problem is gas exchange, left ventricular output, right ventricular output, or combined failure prevents selection of an inadequate device.

Mechanical circulatory support does not make the brain immune to hypotension, hypoxemia, embolism, or hemorrhage. Cannulation, anticoagulation, changing pulsatility, and device-related hemolysis add risks. Sedation and paralysis can hide new deficits, so document the examination before support when feasible and plan repeated neurologic assessments during treatment.

Counterpulsation and Temporary Ventricular Support

An intra-aortic balloon pump (IABP) inflates in diastole to augment diastolic aortic pressure and coronary perfusion, then deflates before systole to reduce LV afterload. It requires correct timing and provides limited support rather than replacing cardiac output. Severe aortic regurgitation and aortic dissection are important contraindications. Routine IABP placement does not confer a universal survival benefit in myocardial-infarction-related cardiogenic shock; selection is individualized, including selected mechanical complications or bridge situations.

Temporary microaxial or extracorporeal ventricular pumps can provide more active flow. Choice depends on ventricular function, anatomy, vascular access, valve disease, intracardiac thrombus, and the team's expertise. LV unloading can improve congestion in selected patients but may also create suction events, hemolysis, vascular injury, or inadequate flow when preload is poor. Device alarms must be evaluated physiologically rather than silenced by repeated fluid boluses without an examination.

VV-ECMO and VA-ECMO

Venovenous ECMO drains systemic venous blood, oxygenates it, removes CO2, and returns it to the venous circulation. The native heart then pumps it systemically. It can support severe reversible respiratory failure despite optimized conventional care. It does not directly correct profound primary cardiogenic shock. Recirculation, cannula position, oxygenator performance, native cardiac output, and hemoglobin influence effective oxygen delivery.

Venoarterial ECMO returns blood to the arterial circulation and can support refractory cardiogenic shock or selected arrest situations. With peripheral femoral return, retrograde aortic flow can increase LV afterload. If the LV cannot eject adequately, ventricular distension and pulmonary edema may develop; specialist unloading strategies may be needed. Lower-body oxygenation may appear satisfactory while poorly oxygenated native LV output supplies the upper body, creating differential hypoxemia. Right-sided upper-extremity oxygenation measurements are useful in this configuration because they better reflect blood reaching the brain than a lower-limb value alone.

Rapid correction of severe hypercapnia at initiation can change cerebral vascular tone abruptly. Coordinate CO2 removal and serial gases rather than assuming an immediate normal number is always harmless. Pump flow, sweep gas, and oxygen delivery are different controls; changing one does not guarantee the expected response in all the others.

Neurologic Complications and Monitoring

Both ischemic stroke and intracranial hemorrhage can occur. Mechanisms include emboli, pre-support hypoxic-ischemic injury, anticoagulation, acquired hemostatic abnormalities, and unstable perfusion. Seizures may be nonconvulsive. Follow pupils, motor responses when assessable, sedation exposure, and gas exchange. EEG, CT, vascular imaging, or other monitoring is selected for the clinical problem; no single bedside monitor excludes a structural lesion.

If a new deficit appears, stabilize systemic support, obtain urgent neuroimaging, and convene the ECMO/device, stroke, neurosurgical, and critical care teams. Decisions about pausing or reversing anticoagulation must consider hemorrhage severity and circuit thrombosis risk together. Standard MRI access may be limited by device compatibility. A safe CT transport plan may resolve a question that cannot be answered at the bedside.

Durable LVAD patients can have low pulsatility, making ordinary cuff pressures and palpable pulses unreliable. Use the device-specific protocol for flow and pressure assessment. Neurologic complications include ischemic stroke, hemorrhage, and infection-related emboli. Verify device function, blood pressure, anticoagulation, and evidence of infection or pump thrombosis during the workup. Do not infer circulatory arrest solely from an absent palpable pulse in a continuous-flow device patient.

A Device-Based Vignette

A patient on peripheral VA-ECMO develops poor right-arm oxygenation despite reassuring lower-limb measurements. The key is to assess differential upper-body hypoxemia, native lung function, ventricular ejection, and circuit configuration. Simply increasing a sedative infusion for agitation may obscure a sign of inadequate cerebral oxygen delivery. A separate patient with preserved circulation and isolated refractory ARDS would generally require consideration of respiratory support, not automatic selection of an arterial circuit.

Source checked October 17, 2026: ELSO clinical guidelines and consensus statements, including neurologic monitoring guidance. Device selection and emergency management depend on configuration and center expertise.